Hyderabad-based pharma company Hetero Drugs Ltd said on Monday that it had been chosen by the Clinton Research Foundation as one of the four Indian pharmaceutical companies that would supply HIV/AIDS drugs to four African and nine Caribbean nations.
AIDS drug: Indian cos, Clinton Foundation ink pact
Slide Show: Clinton declares war on AIDS
HDL range of three drug combinations, namely 'Nevirapine', 'Lamivudine', 'Stavudine', were available at a price that AIDS patients in India could afford, chairman and managing director HDL B P S Reddy told reporters on Monday.
He said HDL had enabled progressive reduction of prices in the Indian market over the years and the move would benefit about two million people through this agreement in the next five years.
